112 related articles for article (PubMed ID: 31527616)
1. CXCL16 positively correlated with M2-macrophage infiltration, enhanced angiogenesis, and poor prognosis in thyroid cancer.
Kim MJ; Sun HJ; Song YS; Yoo SK; Kim YA; Seo JS; Park YJ; Cho SW
Sci Rep; 2019 Sep; 9(1):13288. PubMed ID: 31527616
[TBL] [Abstract][Full Text] [Related]
2. CXCL16 promotes tumor metastasis by regulating angiogenesis in the tumor micro-environment of BRAF V600E mutant colorectal cancer.
Deng W; Liu X; Huang S; Wu Z; Alessandro F; Lin Q; Cai Z; Zhang Z; Huang Y; Wang H; Yuan Z
Transl Oncol; 2024 Mar; 41():101854. PubMed ID: 38232513
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis of the clinical value and potential mechanisms of AHNAK2 in papillary thyroid carcinoma.
Xie Z; Lun Y; Li X; He Y; Wu S; Wang S; Sun J; He Y; Zhang J
Aging (Albany NY); 2020 Sep; 12(18):18163-18180. PubMed ID: 32966238
[TBL] [Abstract][Full Text] [Related]
4. Down-Regulation of AHNAK2 Inhibits Cell Proliferation, Migration and Invasion Through Inactivating the MAPK Pathway in Lung Adenocarcinoma.
Wang DW; Zheng HZ; Cha N; Zhang XJ; Zheng M; Chen MM; Tian LX
Technol Cancer Res Treat; 2020; 19():1533033820957006. PubMed ID: 33000678
[TBL] [Abstract][Full Text] [Related]
5. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma.
Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z
Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605
[TBL] [Abstract][Full Text] [Related]
6. AHNAK Nucleoprotein 2 Performs a Promoting Role in the Proliferation and Migration of Uveal Melanoma Cells.
Li M; Liu Y; Meng Y; Zhu Y
Cancer Biother Radiopharm; 2019 Dec; 34(10):626-633. PubMed ID: 31621397
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell-derived CXCL16 promotes progression of gastric cancer cells by STAT3-mediated expression of Ror1.
Ikeda T; Nishita M; Hoshi K; Honda T; Kakeji Y; Minami Y
Cancer Sci; 2020 Apr; 111(4):1254-1265. PubMed ID: 32012403
[TBL] [Abstract][Full Text] [Related]
8. AHNAK2 is a novel prognostic marker and correlates with immune infiltration in papillary thyroid cancer: Evidence from integrated analysis.
Zheng L; Li S; Zheng X; Guo R; Qu W
Int Immunopharmacol; 2021 Jan; 90():107185. PubMed ID: 33218938
[TBL] [Abstract][Full Text] [Related]
9. The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases.
Korbecki J; Bajdak-Rusinek K; Kupnicka P; Kapczuk P; Simińska D; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33800554
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.
Korbecki J; Kojder K; Kapczuk P; Kupnicka P; Gawrońska-Szklarz B; Gutowska I; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467722
[TBL] [Abstract][Full Text] [Related]
11. Exosomes derived from
Guo S; Chen J; Chen F; Zeng Q; Liu WL; Zhang G
Gut; 2020 Nov; ():. PubMed ID: 33172926
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of Macrophage Density in the Absence of Neutrophils in Differentiated Thyroid Cancer.
Onuma AE; Schoenfield L; Shen C; Edwards C; Phay JE; Shirley LA; Tsung A
J Surg Res; 2020 Dec; 256():458-467. PubMed ID: 32798993
[TBL] [Abstract][Full Text] [Related]
13. Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment.
Xie Z; Li X; He Y; Wu S; Wang S; Sun J; He Y; Lun Y; Zhang J
Front Endocrinol (Lausanne); 2020; 11():570604. PubMed ID: 33193087
[TBL] [Abstract][Full Text] [Related]
14. CXCR6 expressing T cells: Functions and role in the control of tumors.
Mabrouk N; Tran T; Sam I; Pourmir I; Gruel N; Granier C; Pineau J; Gey A; Kobold S; Fabre E; Tartour E
Front Immunol; 2022; 13():1022136. PubMed ID: 36311728
[TBL] [Abstract][Full Text] [Related]
15. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
16. AHNAK2 Promotes Migration, Invasion, and Epithelial-Mesenchymal Transition in Lung Adenocarcinoma Cells via the TGF-β/Smad3 Pathway.
Liu G; Guo Z; Zhang Q; Liu Z; Zhu D
Onco Targets Ther; 2020; 13():12893-12903. PubMed ID: 33363388
[TBL] [Abstract][Full Text] [Related]
17. Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pancreatic ductal adenocarcinoma.
Lee HK; Kim SY; Chung SH; Choi B; Kim JE; Yoon D; Jang SI; Yeo A; Kang HG; Lee J; Choi YH; Park JS; Sung Y; Kim JK; Chang EJ; Lee DK
Br J Cancer; 2024 Apr; ():. PubMed ID: 38643339
[TBL] [Abstract][Full Text] [Related]
18. Effect of nonsteroidal anti-inflammatory drugs (aspirin and naproxen) on inflammation-associated proteomic profiles in mouse plasma and prostate during TMPRSS2-ERG (fusion)-driven prostate carcinogenesis.
Prasad RR; Mishra N; Kant R; Fox JT; Shoemaker RH; Agarwal C; Raina K; Agarwal R
Mol Carcinog; 2024 Jun; 63(6):1188-1204. PubMed ID: 38506376
[TBL] [Abstract][Full Text] [Related]
19. Genomic alterations in oral multiple primary cancers.
Zhou X; Cai X; Jing F; Li X; Zhang J; Zhang H; Li T
Int J Oral Sci; 2024 Feb; 16(1):13. PubMed ID: 38368361
[TBL] [Abstract][Full Text] [Related]
20. The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context.
Chia TY; Billingham LK; Boland L; Katz JL; Arrieta VA; Shireman J; Rosas AL; DeLay SL; Zillinger K; Geng Y; Kruger J; Silvers C; Wang H; Vazquez Cervantes GI; Hou D; Wang S; Wan H; Sonabend A; Zhang P; Lee-Chang C; Miska J
Front Immunol; 2023; 14():1331287. PubMed ID: 38299146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
